Work

What are the benefits and harms of nabiximols (THC and CBD) for adults with opioid-refractory cancer pain?

Year: 2026

Type: article

Abstract: Nabiximols (THC and CBD) show no significant benefit over placebo in managing opioid-refractory cancer pain, and no increased risk of serious adverse effects; thus, it should not be a recommended treatment in this context.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.24001352

Author: Tripdatabase

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7225422988

FWCI:

Cites:

Cited by:

Related to: 10